ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Dependence and clinical fragility in hematopoietic stem cell transplant and CAR-T therapy: a retrospective study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAutologous and allogeneic hematopoietic stem cell transplantation and CAR-T cell therapy are standard treatments for patients affected by hematologic malignancies at different stages of their clinical pathway. Several adverse events accompany these therapies during patients' hospital stay, including psycho-emotional distress and various functional and social impairments.
methodsIn this monocentric study on 498 patients, various clinical and social fragility indices, registered within clinical documentation during the hospital stay, specifically at admission (within 24 h of entry) and discharge (less than 24 h prior to leaving), were retrospectively assessed with the aim of describing their trends and evaluating for differences between type of cell therapy and underlying disease.
resultsFunctional independence mean score was lower in allogeneic patients at admission (p = 0.001) and at discharge (p = 0.001), while a higher risk of falling at discharge (p = 0.001), an increased risk of clinical deterioration at admission (p = 0.001) and at discharge (p = 0.011), and increased complexity of care at both time points (p = 0.001) were observed in patients undergoing CAR-T compared to patients undergoing allogeneic or autologous HSCT procedures. Acute lymphoid leukemia patients had significantly worse mean scores at both time points for functional independence, risk of falling, clinical deterioration, care complexity, level of pain (p = < 0.001); while acute myeloid leukemia patients had higher risk of skin pressure injuries at discharge (p = 0.036).
conclusionOur findings may contribute to improving personalized assessment strategies in the field of cell therapy, including both CAR-T therapy and stem cell transplantation. They highlight the increased risk and complexity of care, particularly in patients receiving CAR-T therapy, while emphasizing the need for tailored management approaches across different cell therapy modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.